ŌURA maker of the world’s most trusted smart ring, Oura Ring, and LillyDirect, Eli Lilly and Company’s digital health platform designed to connect people living with chronic conditions to the care, support, and prescribed medicines they need, today announced a collaboration enabling savings on the Oura Ring sizing kit. The companies will coordinate to improve access to prescribed treatment and integrated behavioral support tools that complement prescribed GLP-1 treatments.
Through the collaboration, LillyDirect customers will be eligible to receive a free Oura Ring sizing kit. The effort is part of a shared healthcare strategy that builds bridges across pharmaceutical companies and technology companies, helping to foster a digital health ecosystem that empowers patients to adopt healthy daily habits in line with clinical guidance for FDA-approved medicines.
“At Lilly, we’re thinking about what patients need throughout their entire care journey, not just at the point of prescription but in the daily moments that shape long-term success,” said Jennifer Mazur, senior vice president of U.S. LillyDirect and Consumer Services, Eli Lilly and Company. “This is about building a more complete ecosystem around the patient.”
Over half of Oura Members identify as having obesity or being overweight, and tens of thousands already log their GLP-1 therapy use in the app—a number expected to climb as these medicines become more widely available, with global adoption projected to exceed 100 million people by 2030.
A Broader Ecosystem of Care for People on GLP-1 Therapies
Oura Ring and the Oura App provide continuous, biometric tracking across Sleep, Readiness, Activity, and other key physiological signals. Last month, Oura introduced GLP-1 Insights, a dedicated companion experience designed to support people using GLP-1 therapy by combining biometric data with GLP-1-specific context to deliver a more holistic view of progress and overall health.
“As more people use GLP-1 therapies, there’s an opportunity to better support the day-to-day habits that influence outcomes,” said Ricky Bloomfield, MD, chief medical officer at Oura. “By integrating daily habits with real-time biometric insights, we can offer a more connected and personalized approach to support lasting results—not just in weight on the scale, but in how people feel and function every day.”
Source: BioSpace
Pingback: Monash University and Brigham and Women's Hospital to Advance Innovation in Sleep and Circadian Medicine - SleepWorld Magazine